Showing results (1081-1090 of 3,790) with videos related to

Sort By:
Pageof 379
Oncoimmunology|December 22, 2016
Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responsesChristian Hotz, Marina Treinies, Ines Mottas, et al.
Oncoimmunology|December 22, 2016
Tumor-associated neutrophils display a distinct N1 profile following TGFβ modulation: A transcriptomics analysis of pro- vs. antitumor TANsMerav E Shaul, Liran Levy, Jing Sun, et al.
Oncoimmunology|December 22, 2016
Novel immunotherapy for adult T-cell leukemia/lymphoma: Targeting aurora kinase ANicholas Paul Casey, Hiroshi Fujiwara, Toshiki Ochi, et al.
Oncoimmunology|December 22, 2016
Erratum
Oncoimmunology|March 28, 2017
Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefitAhmad A Tarhini, Yan Lin, Hui-Min Lin, et al.
Oncoimmunology|March 28, 2017
Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapySadia Zafar, Suvi Parviainen, Mikko Siurala, et al.
Oncoimmunology|March 28, 2017
CAR T-cell intrinsic PD-1 checkpoint blockade: A two-in-one approach for solid tumor immunotherapyNan Chen, Aurore Morello, Zachary Tano, et al.
Oncoimmunology|April 14, 2017
PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcomaJan Budczies, Gunhild Mechtersheimer, Carsten Denkert, et al.
Oncoimmunology|April 14, 2017
MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potentialNatalie J Tigue, Lisa Bamber, John Andrews, et al.
Oncoimmunology|April 14, 2017
Oral delivery of tumor microparticle vaccines activates NOD2 signaling pathway in ileac epithelium rendering potent antitumor T cell immunityWenqian Dong, Huafeng Zhang, Xiaonan Yin, et al.
Pageof 379